Long-Term Survival After Acute Myocardial Infarction and Relation to Type 2 Diabetes and Other Risk Factors

被引:26
作者
Gruppetta, Mark [1 ]
Calleja, Neville [3 ]
Fava, Stephen [1 ,2 ,3 ]
机构
[1] Mater Dei Hosp, Diabet & Endocrine Ctr, Msida, Malta
[2] Univ Malta, Dept Med, Msida, Malta
[3] Univ Malta, Dept Publ Hlth, Msida, Malta
关键词
CORONARY-HEART-DISEASE; FOLLOW-UP; THROMBOLYTIC THERAPY; PRIMARY ANGIOPLASTY; CLINICAL-TRIAL; MELLITUS; MORTALITY; IMPACT; FIBRINOLYSIS; INHIBITION;
D O I
10.1002/clc.20776
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background: Diabetes mellitus (DM) is well established as a short-term prognostic indicator after myocardial infarction (MI), but little long-term data are available. Hypothesis: The objective of the study was to assess the impact of DM and other patient characteristics at baseline on long-term mortality after acute MI. Methods: Patients who were hospitalized with MI from December 1990 to November 1992 were recruited. Baseline data were recorded and patients were followed up through January 31, 2008, to assess their survival rates. Survival curves were generated by the Kaplan-Meier method. The main outcome measure was long-term survival (median 16.6 y). Results: The study followed 337 patients (mean age 66.4 y, 61.1% men) for a median of 16.6 years. Using Cox regression analysis, survival was associated with history of MI (hazard ratio [H RI: 1.47, P = 0.016), DM at baseline (HR: 1.31, P = 0.038), and age (HR: 1.061 for each additional year, P < 0.001). By multivariable regression, cardiovascular mortality was also associated with previous MI (HR: 1.58, P = 0.017), DM at baseline (HR: 1.69, P = 0.001), and age (HR: 1.075 for each additional year, P < 0.001). There was no statistically significant difference between the HRs for history of MI and history of DM. Conclusions: Diabetic patients with MI have a higher long-term all-cause and cardiovascular mortality. Our data also show that in patients with MI, DM confers the same level of risk as a previous MI. This extends to patients with documented MI, our concept of diabetes being a coronary heart disease equivalent. Based on this and on data from the literature, we propose that it would be more accurate to consider DM as an MI equivalent rather than a coronary heart disease equivalent.
引用
收藏
页码:424 / 429
页数:6
相关论文
共 31 条
[1]
SIGNIFICANCE OF DIABETES-MELLITUS IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION RECEIVING THROMBOLYTIC THERAPY [J].
BARBASH, GI ;
WHITE, HD ;
MODAN, M ;
VANDEWERF, F .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (03) :707-713
[2]
Ten-year survival after acute myocardial infarction: Comparison of patients with and without diabetes [J].
Behar, S ;
Boyko, V ;
ReicherReiss, H ;
Goldbourt, U .
AMERICAN HEART JOURNAL, 1997, 133 (03) :290-296
[3]
Amplified benefit of Clopidogrel versus aspirin in patients with diabetes mellitus [J].
Bhatt, DL ;
Marso, SP ;
Hirsch, AT ;
Ringleb, PA ;
Hacke, W ;
Topol, EJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (06) :625-+
[4]
Is primary angioplasty more effective than prehospital fibrinolysis in diabetics with acute myocardial infarction? Data from the CAPTIM randomized clinical trial [J].
Bonnefoy, E ;
Steg, PG ;
Chabaud, S ;
Dubien, PY ;
Lapostolle, F ;
Boudet, F ;
Lacroute, JM ;
Dissait, F ;
Vanzetto, G ;
Leizorowicz, A ;
Touboul, P .
EUROPEAN HEART JOURNAL, 2005, 26 (17) :1712-1718
[5]
FACTORS THAT INFLUENCE OUTCOME IN DIABETIC SUBJECTS WITH MYOCARDIAL-INFARCTION [J].
FAVA, S ;
AZZOPARDI, J ;
MUSCAT, HA ;
FENECH, FF .
DIABETES CARE, 1993, 16 (12) :1615-1618
[6]
OUTCOME OF PATIENTS WITH DIABETES-MELLITUS AND ACUTE MYOCARDIAL-INFARCTION TREATED WITH THROMBOLYTIC AGENTS [J].
GRANGER, CB ;
CALIFF, RM ;
YOUNG, S ;
CANDELA, R ;
SAMAHA, J ;
WORLEY, S ;
KEREIAKES, DJ ;
TOPOL, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 21 (04) :920-925
[7]
Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition - Lessons from the GUSTO V trial [J].
Gurm, HS ;
Lincoff, AM ;
Lee, D ;
Tang, WHW ;
Jia, G ;
Booth, JE ;
Califf, RM ;
Ohman, EM ;
Van de Werf, F ;
Armstrong, PW ;
Guetta, V ;
Wilcox, R ;
Topol, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (04) :542-548
[8]
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].
Haffner, SM ;
Lehto, S ;
Rönnemaa, T ;
Pyörälä, K ;
Laakso, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234
[9]
The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women - 20 years of follow-up [J].
Hu, FB ;
Stampfer, MJ ;
Solomon, CG ;
Liu, SM ;
Willett, WC ;
Speizer, FE ;
Nathan, DM ;
Manson, JE .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (14) :1717-1723
[10]
Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies [J].
Huxley, R ;
Barzi, F ;
Woodward, M .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7533) :73-76